By: Owen McCarthy, President & Co-Founder, MedRhythms MedRhythms strives to keep its finger on the pulse of the digital therapeutics (DTx) industry in order to draw actionable insights about an industry that has the promise of improving clinical outcomes for millions. An important part of this process has been systematically…

Brian Harris, Owen McCarthy, Jennifer Lavanture, and Lauren Steidl The unfolding COVID-19 pandemic has profoundly affected our way of life by limiting our ability to move, to work, and to interact with others. We are increasingly aware of the toll this takes on mental health and morale at the individual…

Over the past few years, digital therapeutics have emerged as a new asset class in healthcare. Recently, the digital therapeutics industry has seen significant growth and market traction, as evidenced by multiple FDA approvals, reimbursement from payors, large commercial deals, successful clinical trials, and investment in the area. These developments…